Michael Atkinson

Prof. Dr. Michael Atkinson

Helmholtz Zentrum München German Research Center for Envrionmental Health, Institute of Radiation Biology Ingolstädter Landstraße 1 D-85764 Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
NPNatalia S. Pellegata
Natalia S. Pellegata
LQLeticia Quintanilla-Martinez
Leticia Quintanilla-Martinez
HSHeide Siggelkow
Heide Siggelkow
ESElenore Samson
Elenore Samson
KBKarin Bink
Karin Bink
MAMichael Atkinson
Michael Atkinson
MENX is a recessive multiple endocrine neoplasia-like syndrome in the rat. The tumor spectrum in MENX overlaps those of human multiple endocrine neoplasia (MEN) types 1 and 2. We mapped the MenX locus to the distal part of rat chromosome 4, excluding the homologs of the genes responsible for the MEN syndromes ( RET and MEN1 ) and syndromes with an endocrine tumor component ( VHL and NF1 ). We report the fine mapping of the disease locus and the identification of a homozygous frameshift mutation in Cdkn1b , encoding the cyclin-dependent kinase inhibitor p27 Kip1 . As a consequence of the mutation, MENX-affected rats show dramatic reduction in p27 Kip1 protein. We have identified a germ-line nonsense mutation in the human CDKN1B gene in a MEN1 mutation-negative patient presenting with pituitary and parathyroid tumors. Expanded pedigree analysis shows that the mutation is associated with the development of an MEN1-like phenotype in multiple generations. Our findings demonstrate that germ-line mutations in p27 Kip1 can predispose to the development of multiple endocrine tumors in both rats and humans.

1 February 1996 in Bone
Verified
Journal Article
Closed access
AWA. Wetterwald
A. Wetterwald
WHW. Hofstetter
W. Hofstetter
MCM.G. Cecchini
M.G. Cecchini
BLB. Lanske
B. Lanske
CWC. Wagner
C. Wagner
MAMichael Atkinson
Michael Atkinson

1 April 2015 in Cell Reports
Verified
Journal Article
Open access
VOValerie O'Leary
Valerie O'Leary
SOSaak Victor Ovsepian
Saak Victor Ovsepian
LCLaura Garcia Carrascosa
Laura Garcia Carrascosa
FBFabian Andreas Buske
Fabian Andreas Buske
VRVanja Radulovic
Vanja Radulovic
NANataša Anastasov
Nataša Anastasov
Exposure to low-dose irradiation causes transiently elevated expression of the long ncRNA PARTICLE (gene PARTICLE, promoter of MAT2A-antisense radiation-induced circulating lncRNA). PARTICLE affords both a cytosolic scaffold for the tumor suppressor methionine adenosyltransferase (MAT2A) and a nuclear genetic platform for transcriptional repression. In situ hybridization discloses that PARTICLE and MAT2A associate together following irradiation. Bromouridine tracing and presence in exosomes indicate intercellular transport, and this is supported by ex vivo data from radiotherapy-treated patients. Surface plasmon resonance indicates that PARTICLE forms a DNA-lncRNA triplex upstream of a MAT2A promoter CpG island. We show that PARTICLE represses MAT2A via methylation and demonstrate that the radiation-induced PARTICLE interacts with the transcription-repressive complex proteins G9a and SUZ12 (subunit of PRC2). The interplay of PARTICLE with MAT2A implicates this lncRNA in intercellular communication and as a recruitment platform for gene-silencing machineries through triplex formation in response to irradiation.

15 July 1994
Verified
Journal Article
Closed access
KBK F Becker
K F Becker
MAMichael Atkinson
Michael Atkinson
URU Reich
U Reich
IBI Becker
I Becker
HNH Nekarda
H Nekarda
HHH Höfler
H Höfler

1 August 2009 in Nature Reviews Cancer
Verified
Journal Article
Closed access
LMLeon Mullenders
Leon Mullenders
MAMichael Atkinson
Michael Atkinson
HPHerwig Paretzke
Herwig Paretzke
LSLaure Sabatier
Laure Sabatier
SBSimon Bouffler
Simon Bouffler

23 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LMLisa Mutschelknaus
Lisa Mutschelknaus
CPCarsten Peters
Carsten Peters
KWKlaudia Winkler
Klaudia Winkler
RYRamesh Yentrapalli
Ramesh Yentrapalli
THTheresa Heider
Theresa Heider
SMSimone Moertl
Simone Moertl
Exosomes are nanometer-sized extracellular vesicles that are believed to function as intercellular communicators. Here, we report that exosomes are able to modify the radiation response of the head and neck cancer cell lines BHY and FaDu. Exosomes were isolated from the conditioned medium of irradiated as well as non-irradiated head and neck cancer cells by serial centrifugation. Quantification using NanoSight technology indicated an increased exosome release from irradiated compared to non-irradiated cells 24 hours after treatment. To test whether the released exosomes influence the radiation response of other cells the exosomes were transferred to non-irradiated and irradiated recipient cells. We found an enhanced uptake of exosomes isolated from both irradiated and non-irradiated cells by irradiated recipient cells compared to non-irradiated recipient cells. Functional analyses by exosome transfer indicated that all exosomes (from non-irradiated and irradiated donor cells) increase the proliferation of non-irradiated recipient cells and the survival of irradiated recipient cells. The survival-promoting effects are more pronounced when exosomes isolated from irradiated compared to non-irradiated donor cells are transferred. A possible mechanism for the increased survival after irradiation could be the increase in DNA double-strand break repair monitored at 6, 8 and 10 h after the transfer of exosomes isolated from irradiated cells. This is abrogated by the destabilization of the exosomes. Our results demonstrate that radiation influences both the abundance and action of exosomes on recipient cells. Exosomes transmit prosurvival effects by promoting the proliferation and radioresistance of head and neck cancer cells. Taken together, this study indicates a functional role of exosomes in the response of tumor cells to radiation exposure within a therapeutic dose range and encourages that exosomes are useful objects of study for a better understanding of tumor radiation response.